Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,201 | -9,843 | -7,556 | -4,489 | -2,217 |
| Depreciation Amortization | N/A | 771 | 771 | 771 | 193 |
| Other Working Capital | -22 | -857 | 429 | 353 | -19 |
| Other Operating Activity | 22 | 682 | -56 | -62 | -69 |
| Operating Cash Flow | $-2,201 | $-9,246 | $-6,411 | $-3,427 | $-2,112 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,000 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $4,000 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 2,456 | 2,623 | 2,229 | 2,229 |
| Common Stock Issued | 79 | 2,634 | 2,635 | 2,635 | 2,635 |
| Other Financing Activity | -171 | 11,691 | 11,691 | -329 | -196 |
| Financing Cash Flow | $-92 | $16,781 | $16,950 | $4,535 | $4,668 |
| Beginning Cash Position | 4,400 | 865 | 865 | 865 | 865 |
| End Cash Position | 6,107 | 8,400 | 11,404 | 1,974 | 3,421 |
| Net Cash Flow | $1,707 | $7,535 | $10,539 | $1,109 | $2,556 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,201 | -9,246 | -6,411 | -3,427 | -2,112 |
| Free Cash Flow | -2,201 | -9,246 | -6,411 | -3,427 | -2,112 |